Learn more

NAT UNIV CORP TOKYO MED & DENT

Overview
  • Total Patents
    201
  • GoodIP Patent Rank
    41,183
About

NAT UNIV CORP TOKYO MED & DENT has a total of 201 patent applications. Its first patent ever was published in 2005. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are UNIV HEALTH NETWORK, INST NAT DE LA SANTE ET DE LA RECH MEDICALE (INSERM) and UNIV SAPPORO MEDICAL.

Patent filings per year

Chart showing NAT UNIV CORP TOKYO MED & DENTs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Mizusawa Hidehiro 26
#2 Yokota Takanori 24
#3 Nishina Kazutaka 22
#4 Kaneko Tomoyuki 14
#5 Yasuda Kenji 14
#6 Takatani Setsuo 14
#7 Nomura Fumimasa 14
#8 Kishida Akio 12
#9 Akiyoshi Kazunari 11
#10 Ishikawa Kinya 9

Latest patents

Publication Filing date Title
WO2016125582A1 Agent for promoting proliferation of mesenchymal stem cells, agent for promoting cartilage differentiation of mesenchymal stem cells, mesenchymal-stem-cell preparation method, chondrocytic-cell preparation method and mesenchymal-stem-cell culture medium
WO2016088797A1 Nucleic acid reducing als-causing protein toxicity
WO2016043286A1 Screening method, method for preparing isolated mesenchymal stem cells, and mesenchymal stem cell isolation device
WO2016021633A1 Biomagnetism measurement device
WO2016002854A1 Preparation used for promotion of proliferation of neural stem cells, preparation used for prevention or treatment of diseases associated with decrease in neural stem cells, preparation used for promotion of formation of postsynapses, preparation used for prevention or treatment of diseases associated with decrease in formation of postsynapses, and screening method
WO2015152146A1 Method for culturing haploid embryonic stem cells
WO2015105198A1 Novel compounds having a tetracyclic iridoid skeleton and an anti-trypanosomal, anti-leishmanial and anti-plasmodial agents comprising the same as an active ingredient
WO2015099094A1 Method for diagnosis of alzheimer's disease and frontotemporal lobar degeneration, diagnostic agent, therapeutic agent, and screening method for said agents
WO2015083685A1 Dlg1/SAP97 GENE SPLICING VARIANT, AND DETECTION OF SCHIZOPHRENIA USING SPLICING VARIANT
WO2015083567A1 Fluid injection-type artificial muscle actuator and manipulator
WO2015053402A1 Drug for prevention or treatment of spinocerebellar degeneration
WO2015030185A1 Opening measurement instrument
WO2014192907A1 Microrna detection method used to differentiate disease exhibiting motor nerve disability
WO2014192312A1 MYOCARDIAL MODEL CELL DERIVED FROM iPS CELL HAVING NORMAL INWARD POTASSIUM CURRENT CHARACTERISTICS
US2016145614A1 Double-stranded agents for delivering therapeutic oligonucleotides
WO2015145702A1 Diphosphate compound detector and diphosphate compound detection method
WO2014148620A1 Double-stranded nucleic acid binder, said binder—double-stranded nucleic acid complex, pharmaceutical composition containing said complex, and production method for said complex
US2016011176A1 Method and device for examining myocardial toxicity and evaluating cardiomyocytes
TW201422208A Evaluation system for brain function and evaluation method for brain function
WO2013129620A1 Composition for increasing bone mass